Clinical Trial Update: Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Nilotinib BE in early Alzheimer's disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nilotinib BE (nilotinib)

Snippet

Sponsor: KeifeRx, LLC | Conditions: Alzheimer Disease | Phase 3 | Status: NOT_YET_RECRUITING